Quantcast

Gene expression analysis of aberrant signaling pathways in meningiomas.

Research paper by Miguel M Torres-Martín, Victor V Martinez-Glez, Carolina C Peña-Granero, Alberto A Isla, Luis L Lassaletta, Jose M JM DE Campos, Giovanny R GR Pinto, Rommel R RR Burbano, Bárbara B Meléndez, Javier S JS Castresana, Juan A JA Rey

Indexed on: 16 Aug '13Published on: 16 Aug '13Published in: Oncology letters



Abstract

Examining aberrant pathway alterations is one method for understanding the abnormal signals that are involved in tumorigenesis and tumor progression. In the present study, expression arrays were performed on tumor-related genes in meningiomas. The GE Array Q Series HS-006 was used to determine the expression levels of 96 genes that corresponded to six primary biological regulatory pathways in a series of 42 meningiomas, including 32 grade I, four recurrent grade I and six grade II tumors, in addition to three normal tissue controls. Results showed that 25 genes that were primarily associated with apoptosis and angiogenesis functions were downregulated and 13 genes frequently involving DNA damage repair functions were upregulated. In addition to the inactivation of the neurofibromin gene, NF2, which is considered to be an early step in tumorigenesis, variations of other biological regulatory pathways may play a significant role in the development of meningioma.